InsiderClue
Insiders · Profile

STARR KEVIN P

10% owner at CytomX Therapeutics · 10% owner at Editas Medicine · Director at ALNYLAM PHARMACEUTICALS · and 1 more. Filing since 25 Mar 2013. CIK 0001192603

CTMX CytomX Therapeutics, Inc. 10% owner · 1 trade EDIT Editas Medicine, Inc. 10% owner · 1 trade ALNY ALNYLAM PHARMACEUTICALS, INC. Director · 6 trades LRMR Larimar Therapeutics, Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
CTMX CytomX Therapeutics, Inc.
12 Apr 2017
10% owner
Sold, plan not stated
28,357
$463.79K
47.4%
EDIT Editas Medicine, Inc.
6 Sep 2016
10% owner
Sold, plan not stated
5,890
$93.67K
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
12 Nov 2015
Director
Sold, plan not stated
37,500
$3.76M
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
11 Nov 2015
Director
Sold, plan not stated
37,500
$4.04M
100%
LRMR Larimar Therapeutics, Inc.
24 Sep 2015
Director
Sold, plan not stated
136,579
$6.00M
39.4%
ALNY ALNYLAM PHARMACEUTICALS, INC.
25 Sep 2014
Director
Sold, plan not stated
45,000
$3.47M
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
24 Sep 2014
Director
Sold, plan not stated
45,000
$3.56M
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
26 Mar 2013
Director
Sold, plan not stated
26,000
$608.58K
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
25 Mar 2013
Director
Sold, plan not stated
26,631
$627.56K
100%
9 decisions on file.